Quarterly report · Q1
4886.TEDINET S100OVV1
Period2022-04-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥56.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.2bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.9bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥84.8bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥83.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥81.7bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.3bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥34.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥50.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥45.3bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥46.94 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.22 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.72 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥44m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥15m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥18m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥15m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥15m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥169m |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.6bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥13.6bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥42m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥30m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥160m |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥103m |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥12.8bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥12.8bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 325
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)清陽監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)野中 信男 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中市 俊也 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)槇田 憲一郎 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 14221000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 15269000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 56607000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1329000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1805000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 4880000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1098000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1323000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 4290000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 986000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1792000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 4982000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 45313000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 50477000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 48892000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 81717000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 84764000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 83297000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 38.72 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 46.94 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 151.22 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.555 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.596 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.587 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30563199 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30563199 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 30563199 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 30563199 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 2321300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 28220700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 282207 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 21199 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 30563199 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 282207 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 2321300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 2321300 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |